ONC Q4 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.1B+77.8% YoY

Gross Profit

$967M85.8% margin

Operating Income

-$79M-7.0% margin

Net Income

-$152M-13.5% margin

EPS (Diluted)

$-1.43

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

$75M

Free Cash Flow

-$17M

Stock-Based Comp.

$108M

Balance Sheet

Total Assets

$5.9B

Total Liabilities

$2.6B

Stockholders' Equity

$3.3B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$634M	+77.8%
Gross Profit	$967M	$529M	+83.0%
Operating Income	-$79M	-$384M	+79.3%
Net Income	-$152M	-$368M	+58.7%